Related Experiment Videos
[Immunologic phenotype of malignant lymphoma]
1Hematology-Oncology and Medical Oncology Division, National Cancer Center Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 1, 1992
Summary
This review covers advances in surface marker analysis for classifying malignant lymphoma. New classifications are proposed based on immunophenotypic analysis and clinical data for T-cell and B-cell malignancies.
Area of Science:
- Hematology
- Oncology
- Immunology
Context:
- Malignant lymphoma classification relies on surface marker analysis.
- Flow cytometry and immunohistochemistry are key diagnostic tools.
- Recent clinical research provides new insights into lymphoid malignancies.
Purpose:
- To review recent advances in surface marker analysis for malignant lymphoma.
- To propose a new clinicopathologic classification of lymphoid malignancy.
- To discuss specific T-cell and B-cell lymphoma subtypes.
Summary:
- Surface marker analysis, using flow cytometry and immunohistochemistry, aids in classifying malignant lymphoma into T-cell or B-cell types.
- A novel clinicopathologic classification is proposed, integrating immunophenotypic data and clinical findings.
- The review highlights T-cell receptor gamma delta-type T-cell malignancies and various B-cell lymphomas, including those associated with HIV and EBV.
Impact:
- Facilitates more accurate diagnosis and classification of malignant lymphomas.
- Informs the development of targeted therapies for specific lymphoma subtypes.
- Advances the understanding of lymphoid malignancy pathogenesis and clinical behavior.